Laboratorios Farmaceuticos Rovi, S.A. Stock Wiener Boerse
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.80 EUR | -1.30% |
|
-1.30% | -10.27% |
| May. 13 | Spanish stocks - Factors to watch on May 13 | RE |
| May. 09 | Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026 |
| Market Cap | 2.87B 3.28B 2.65B 2.45B 4.65B 313B 4.73B 31.72B 12.43B 154B 12.33B 12.06B 533B | P/E 2026 * |
21.5x | P/E 2027 * | 16.2x |
|---|---|---|---|---|---|
| Enterprise Value | 2.84B 3.25B 2.62B 2.43B 4.61B 310B 4.68B 31.41B 12.31B 152B 12.21B 11.94B 528B | EV / Sales 2026 * |
3.67x | EV / Sales 2027 * | 3.1x |
| Free-Float |
31.63% | Yield 2026 * |
1.73% | Yield 2027 * | 1.99% |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| Feb. 25 | Spanish stocks - Factors to watch on Feb 25 | RE |
| Nov. 06 | Spanish stocks - Factors to watch on Nov 6 | RE |
| 25-03-05 | Spanish stocks - Factors to watch on March 5 | RE |
| 1 day | -1.30% | ||
| 1 week | -1.30% | ||
| Current month | -1.90% | ||
| 1 month | -1.73% | ||
| 3 months | -31.07% | ||
| 6 months | -17.44% | ||
| Current year | -10.27% |
| 1 week | 56.2 |  | 57.65 |
| 1 month | 56.2 | | 59.6 |
| Current year | 56.2 | | 86.6 |
| 1 year | 51.85 | | 86.6 |
| 3 years | 38.38 | | 90.75 |
| 5 years | 35.64 | | 90.75 |
| 10 years | 35.64 | | 90.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2007-07-26 | |
| Director of Finance/CFO | - | 2000-12-31 | |
| Chief Tech/Sci/R&D Officer | - | 2013-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2021-07-16 | |
| Director/Board Member | - | 2007-07-26 | |
| Director/Board Member | - | 2007-07-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.30% | -1.30% | - | - | 3.27B | |
| +0.09% | +0.25% | +54.65% | +169.19% | 1,084B | |
| -1.63% | -1.50% | +65.79% | +62.70% | 634B | |
| -1.12% | -4.27% | +31.10% | +84.44% | 447B | |
| +0.18% | -1.76% | +29.04% | +26.51% | 330B | |
| -6.22% | -8.14% | +28.87% | +32.09% | 295B | |
| -1.27% | -2.91% | +27.42% | +46.39% | 285B | |
| -0.93% | -3.57% | -27.74% | -40.38% | 218B | |
| -1.19% | -2.81% | +22.63% | +66.30% | 199B | |
| -0.72% | +2.72% | +19.07% | +81.19% | 169B | |
| Average | -1.28% | -1.27% | +27.87% | +58.71% | 406.65B | |
| Weighted average by Cap. | -0.90% | -1.18% | +38.91% | +84.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 774M 885M 714M 660M 1.25B 84.46B 1.27B 8.55B 3.35B 41.47B 3.32B 3.25B 144B | 898M 1.03B 828M 766M 1.45B 98.01B 1.48B 9.92B 3.89B 48.13B 3.85B 3.77B 167B |
| Net income | 133M 152M 123M 113M 215M 14.51B 219M 1.47B 576M 7.13B 571M 558M 24.68B | 178M 203M 164M 152M 288M 19.38B 292M 1.96B 769M 9.52B 762M 746M 32.96B |
| Net Debt | -27.87M -31.86M -25.7M -23.78M -45.14M -3.04B -45.89M -308M -121M -1.49B -120M -117M -5.17B | -85.9M -98.19M -79.21M -73.29M -139M -9.37B -141M -949M -372M -4.6B -369M -361M -15.94B |
| Date | Price | Change |
|---|---|---|
| 26-07-09 | €56.25 | +0.09% |
| 26-07-08 | €56.20 | -1.75% |
| 26-07-07 | €57.20 | 0.00% |
| 26-07-06 | €57.20 | +0.70% |
| 26-07-03 | €56.80 | -1.30% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
- ROVI Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
